700 migraine patients tracked to see how well newer drugs really work
NCT ID NCT07159750
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This observational study will follow 700 people with migraine who are prescribed anti-CGRP drugs (monoclonal antibodies or gepants) for prevention. Over two years, researchers will track changes in monthly headache days, migraine impact, and disability. The goal is to see how these treatments perform in real-world settings, outside of controlled clinical trials.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Anti-CGRP drugs (monoclonal antibodies: erenumab, galcanezumab, fremanezumab, eptinezumab; gepants: rimegepant, atogepant)
What this could lead to
If successful, this study could provide real-world evidence on how well these migraine preventives work in everyday practice, helping doctors choose the best treatment for each patient.
What could go wrong
This is an observational study, not a controlled trial, so results may be influenced by patient selection and other factors. It does not test new drugs but observes existing ones, so no new treatment will emerge directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Charité Universitätsmedizin Berlin
RECRUITINGBerlin, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
FLENI
RECRUITINGBuenos Aires, Argentina
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Fundació Sanitària Mollet
NOT_YET_RECRUITINGMollet del Vallès, Barcelona, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Fundación Jiménez Díaz
RECRUITINGMadrid, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Germans Trias i Pujol Hospital
RECRUITINGBadalona, Barcelona, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital Clínico Universitario Lozano Blesa
RECRUITINGZaragoza, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital General Universitario de Albacete
RECRUITINGAlbacete, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital Santa Maria Lisbon
RECRUITINGLisbon, Portugal
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital Universitari de Bellvitge
RECRUITINGL'Hospitalet de Llobregat, Barcelona, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital Universitario Gregorio Marañón
RECRUITINGMadrid, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital de Viladecans
RECRUITINGViladecans, Barcelona, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
IRCCS San Raffaele
RECRUITINGRoma, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
LMU University Hospital
RECRUITINGMünchen, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
La Paz University Hospital
RECRUITINGMadrid, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Mersin University
RECRUITINGMersin, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
National Neurological Institute C. Mondino Foundation
RECRUITINGPavia, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Neuroclinic Norway
RECRUITINGLillestrøm, Norway
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Neuromedica
RECRUITINGMedellín, Colombia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Pontificia Universidad Católica de Chile
RECRUITINGSantiago, Chile
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Special Hospital for Orthopedics and Rehabilitation "Martin Horvat" Rovinj-Rovigno
RECRUITINGRovinj, Croatia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Universiti Putra Malaysia
RECRUITINGSerdang, Selangor, Malaysia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of L'Aquila
RECRUITINGL’Aquila, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Miami, Miller School of Medicine
RECRUITINGMiami, Florida, 33136, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Modena and Reggio Emilia
RECRUITINGModena, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Vall d'Hebron University Hospital
RECRUITINGBarcelona, Barcelona, 08035, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Wrocław Medical University
RECRUITINGWroclaw, Poland
Contact Phone: •••-•••-•••• Email: •••••@•••••